| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.54B | +49.1% |
| Cost of Revenue | $5.37B | +32.2% |
| Gross Profit | $5.16B | +71.8% |
| R&D Expense | $1.10B | +86.2% |
| SG&A Expense | $661.0M | +42.3% |
| Operating Income | $1.03B | +134.6% |
| Pre-tax Income | $780.0M | +224.2% |
| Income Tax | $298.0M | +100.3% |
| Net Income | $482.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.91B | -26.1% |
| Short-term Investments | $2.34B | +188.9% |
| Accounts Receivable | $130.0M | +32.4% |
| Inventory | $152.0M | -39.9% |
| Current Assets | $10.95B | +34.0% |
| Total Assets | $13.74B | +36.0% |
| Current Liabilities | $8.56B | +46.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.94B | +204.6% |
| Capital Expenditures | $454.0M | -20.8% |
| Investing Cash Flow | -$3.87B | -142.5% |
| Financing Cash Flow | $916.0M | -52.4% |
| Free Cash Flow | $2.49B | +534.0% |
| +478.6% |
| EPS (Basic) | $9.57 | +473.1% |
| EPS (Diluted) | $9.53 | +470.7% |
| Long-term Debt |
| $4.76B |
| +35.2% |
| Total Liabilities | $11.91B | +39.0% |
| Stockholders' Equity | $1.83B | +19.3% |